Bizarre Patents
Crispy Chip Sandwich and Process of Producing a Sandwich Product
A food product comprising a multilayer cookie or snack having outer layers formed from a crispy type edible food product such as a potato chip or corn chip, etc. with an intermediate marshmallow layer being in contact with the inner surface of each crispy chip and one or more filler substances.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 8013131 | Synthetic membrane anchors The invention relates to synthetic molecules that spontaneously and stably incorporate into lipid by-layers, including cell membranes. Particularly, although not exclusively, the invention relates to the use of these molecules as synthetic membrane anchors or synthe... | 09/06/2011 |
| 7989602 | Synthetic molecules having immune activity The present invention is directed to synthetic molecules having biological activity similar to PIM (acyl glycerol phosphatidylinositol manno-oligosaccharide) activity, for use in the treatment and prevention of inflammatory or immune cell mediated diseases or disord... | 08/02/2011 |
| 7858761 | 1-α-halo-2,2-difluoro-2-deoxy-D-ribofuranose derivatives and process for the preparation thereof 1-α-halo-2,2-difluoro-2-deoxy-D-ribofuranose derivative of formula (I) having the 3-hydroxy group protected with a biphenylcarbonyl group is a solid which can be easily purified by a simple procedure such as recrystallization, and therefore, it can be advantageousl... | 12/28/2010 |
| 7368439 | Dinucleoside poly(borano)phosphate derivatives and uses thereof The present invention provides dinucleoside boranophosphate derivatives of the general formula I: wherein X and X′ each independently is an unsubstituted or substituted purine or pyrimidine residue; Y and Y′ each independ... | 05/06/2008 |
| 7238823 | Platinum complexes with mononitrile-containing ligands Disclosed herein are novel platinum-based complexes possessing one nitrile substituent group (mononitrile) covalently-bonded to the platinum, one or more nitrogen donor ligands capable of forming hydrogen bonds with the bases in DNA or RNA and leaving groups (i.e., ... | 07/03/2007 |
| 7169392 | serogroup B glycoconjugates and methods of producing the same The present invention pertains generally to novel Neisseria meningitidis serogroup B glycoconjugates. More particularly, the invention pertains to glycoconjugates formed from a Neisseria meningitidis serogroup B capsular oligosaccharide derivative (Men... | 01/30/2007 |
| 7112671 | Non-symmetric tripyrranes in the synthesis of novel macrocycles The present invention provides certain non-symmetric tripyrranes; that is, tripyrranes that do not contain a mirror plane of symmetry perpendicular to the plane containing the tripyrrane. Further, the invention includes texaphyrin compounds and sapphyrin compounds, ... | 09/26/2006 |
| 7109323 | Formulation of boronic acid compounds The invention relates to the formulation of pharmaceutical compounds. More particularly, the invention provides stable, pharmaceutically acceptable compositions prepared from boronic acid compounds and methods for preparing the compositions. The invention also provi... | 09/19/2006 |
| 7105648 | Oligomers substituted by phosphite acid ester, phosphonic acid or carbaborane functions and the corresponding PNA monomers The invention relates to novel oligomers containing PNA units that are substituted by phosphite ester, phosphonic acid, or carbaborane functions and PNA monomers that are substituted by phosphite ester, phosphonic acid, or carbaborane functions, from which the novel... | 09/12/2006 |
| 7078519 | Enzyme catalyzed organosilicon carbohydrates Methods for forming structurally defined organosilicon carbohydrates are provided. Additionally, structurally defined organosilicon carbohydrates are provided. The structurally defined organosilicon carbohydrates may be formed by contacting a hydrolase enzyme with a... | 07/18/2006 |
| 7070801 | Sugar-modified liposome and products comprising the liposome The present invention provides a sugar-modified liposome having a sugar chain bonded to its membrane surface, preferably through a linker protein, and having excellent absorption qualities, particularly in the intestine. The molecular structure and quantity of the s... | 07/04/2006 |
| 7001888 | Compositions and methods for treating cancer Methods and compositions are provided for the treatment of cancer that take advantage of the increased uptake of glucose-anti-neoplastic agent conjugates in cancer cells relative to normal cells. ... | 02/21/2006 |
| 6958319 | Formulation of boronic acid compounds The present invention provides stable compounds prepared from boronic acid and lyophilized compounds thereof of the formula (1): in which Z1 and Z2 are moieties derived from sugar. The invention a... | 10/25/2005 |
| 6906042 | Micelles The invention provides micelles, pharmaceutical formulations comprising micells, solutions comprising micells, methods for preparing micells, methods for delivering micells to patients, and methods for treating sepsis, endotoxemia, septic shock and systemic inflamat... | 06/14/2005 |
| 6900181 | Pharmaceutical composition The present invention concerns analogues of M6P for use in promoting the healing of wounds or fibrotic disorders with reduced scarring, together with methods for doing same. ... | 05/31/2005 |
| 6861512 | Separation of olefinic isomers The geometric isomers of olefins and olefinic compounds are separated by means of liquid chromatography using a stationary phase comprising an organosilane with a pendant aliphatic functional group such as C18 and a mobile phase which includes an additive... | 03/01/2005 |
| 6713446 | Formulation of boronic acid compounds The present invention provides stable compounds prepared from boronic acid and lyophilized compounds thereof of the formula (1): in which Z1 and Z2 are moieties derived from sugar. The invention als... | 03/30/2004 |
| 6699835 | Formulation of boronic acid compounds The invention relates to the formulation of pharmaceutical compounds. More particularly, the invention provides stable, pharmaceutically acceptable compositions prepared from boronic acid compounds and methods for preparing the compositions. The invention... | 03/02/2004 |
| 6657057 | Process for production of methylcobalamin The present invention provides an industrially excellent and novel process for producing methylcobalamin useful as medicines. Namely, it provides a process for producing methylcobalamin, which comprises the step of methylating cyanocobalamin or hydroxocob... | 12/02/2003 |
| 6630577 | 1,2-Phenylenediboronic acid reagents and complexes A reagent having the general formula of General Formula I: ##STR1## wherein group Z comprises a spacer selected from an aliphatic chain up to about 6 carbon equivalents in length, an unbranched aliphatic chain of from about 6 to 18 carbon equivalents in l... | 10/07/2003 |
| 6624317 | Taxoid conjugates as antimitotic and antitumor agents Compounds according to formula I: wherein T1 is a taxoid group, preferably of Formula II: ##STR1## wherein R1 is C6 H5 ; R2 is O; L is a linking group; and T2 is a substituent selected from the ... | 09/23/2003 |
| 6620921 | Glucofuranoses A ଲ-D-glucofuranose compound which is 1,2,3,5,6-penta-O-propanoyl-ଲ-D-glucofuranose, preferably in crystalline form, is prepared from D-glucose. The compound is prepared by reacting D-glucose with boric acid, or an equivalent thereof, followed... | 09/16/2003 |
| 6600026 | Electronic methods for the detection of analytes utilizing monolayers The present invention relates to the use of self-assembled monolayers with mixtures of conductive oligomers and insulators to detect target analytes.... | 07/29/2003 |
| 6566339 | Pharmaceutical composition The present invention concerns analogues of M6P for use in promoting the healing of wounds or fibrotic disorders with reduced scarring, together with methods for doing same.... | 05/20/2003 |
| 6486129 | Antithrombotic compounds ##STR1## The present invention relates to compounds of formula (1), wherein R1 is phenyl, naphthyl, 1,2,3,4-tetrahydronaphthyl, (iso)quinolinyl, tetrahydro(iso)quinolinyl, 3,4-dihydro-1H-isoquinolinyl, chromanyl or the camphor group, which grou... | 11/26/2002 |
| 6462179 | Phenyldiboronic acid reagents and complexes Reagents suitable for the modification of a bioactive species for the purpose of incorporating one or more phenyldiboronic acid (PDBA) moieties for subsequent conjugation to a different (or the same) bioactive species having one or more pendant boronic co... | 10/08/2002 |
| 6426421 | Protecting groups useful in the synthesis of polysaccharides, natural products, and combinatorial libraries One aspect of the present invention relates to optionally substituted halogenated benzyl halides and the like. These compounds are useful as halogenated benzyl ether-based protecting groups for a variety of functional groups. Another aspect of the present... | 07/30/2002 |
| 6414122 | Bifunctional boronic compound complexing reagents and complexes Embodiments include reagents to modify a bioactive species for incorporating a bifunctional boronic compound complexing moiety for subsequent conjugation to a different or same bioactive species having pendant phenylboronic acid moieties of General Formul... | 07/02/2002 |
| 6310042 | Derivatives of carbohydrates and compositions containing them The present invention relates to derivatives of phosphorylated carbohydrates and pharmaceutical compositions comprising as a pharmaceutically active ingredient at least one of these compounds.... | 10/30/2001 |
| 6214978 | Antitumor and anticholesterol preparations containing a lipoteichoic acid from streptococcus The invention concerns a new lipoteichoic acid which can be isolated from the new Streptococcus sp DSM 8747. The new LTA is called LTA-T. It has a lipid anchor, which is a galacto-furanosyl-beta-1-3-glycerol with different rests of fatty acids esterified ... | 04/10/2001 |
| 6184366 | Substituted liposaccharides useful in the treatment and prevention of endotoxemia Novel substituted liposaccharides useful as in the prophylactic and affirmative treatment of endotoxemia including sepsis, septicemia and various forms of septic shock and methods of using these agents are provided. Also provided are methods of preparing ... | 02/06/2001 |
| 6140307 | Pharmaceutical composition The present invention concerns analogues of mannose-6-phosphate for use in promoting the healing of wounds or fibrotic disorders with reduced scarring, and methods for doing same.... | 10/31/2000 |
| 6107284 | Water-soluble derivatives of epipodophyllotoxin, process for their preparation, their use as medicinal products and their intended use in anti-cancer treatments Water-soluble derivatives of epipodophyllotoxin, process for their preparation and their use for the treatment of rheumatoid arthritis, complaints caused by human papilloma virus and cancer.... | 08/22/2000 |
| 6090950 | Chiral hydride complexes Novel chiral boron and aluminum hydride complexes, compositions comprising the chiral hydride complexes, and methods for their synthesis and use are described. The novel chiral hydride complexes are of the formulas: MBH4-n-a (R*)n (R') | 07/18/2000 |
| 6084081 | Lewis X derivatives A novel fluorine-containing Lewis X derivative represented by the following formula (I): ##STR1## wherein R represents hydrogen, a hydroxyl-protective group, --PO(OH)2, --SO3 H or sialylate; R1 represents hydrogen, hy... | 07/04/2000 |
| 6075126 | Phenyldiboronic acid reagents and complexes Boron compound complexing reagents, boron compound complexes, and methods of synthesizing these reagents and complexes are disclosed. These reagents and complexes include those shown in General Formula CIII, General Formula CIV, and General Formula CVI. I... | 06/13/2000 |
| 6072038 | Conjugates of texaphyrins The invention relates to the field of radiation sensitizers and the use of texaphyrins for radiation sensitization and other conditions for which X-ray radiation has proven to be therapeutic.... | 06/06/2000 |
| 6066727 | Organopolysiloxane-grafted polysaccharide compound Disclosed is a novel method for the preparation of an organo-polysiloxane-grafted polysaccharide compound which is particularly useful as an additive ingredient in various types of cosmetic and toiletry preparations. The method utilizes a reaction between... | 05/23/2000 |
| 6057429 | Phosphatase activated crosslinking, conjugating and reducing agents; methods of using such agents; and reagents comprising phosphatase activated crosslinking and conjugating agents The present invention provides crosslinking, conjugating and reducing agents which are functional with at least one phosphorothioate monoester group (--SPO3-2). Crosslinking and conjugation methods as well as solid phase reagents and... | 05/02/2000 |
| 6008406 | Phenylboronic acid complexing reagents derived from aminosalicylic acid The present invention relates to novel class of phenylboronic acid complexing reagents useful for the preparation of bioconjugates, and the method of making and using such reagents. In the present invention, in the place of prior art Avidin-Biotin and Dig... | 12/28/1999 |
